Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 37 entries
Sorted by: Best Match Show Resources per page
Pathophysiologische Grundlagen der Systemtherapien bei Psoriasis.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Volc S, Ghoreschi K.
PMID: 27240059
J Dtsch Dermatol Ges. 2016 Jun;14(6):557-73. doi: 10.1111/ddg.13050_g.

No abstract available.

Cite
Volc S, Ghoreschi K. Pathophysiologische Grundlagen der Systemtherapien bei Psoriasis. J Dtsch Dermatol Ges. 2016;14(6):557-73doi: 10.1111/ddg.13050_g.
Volc, S., & Ghoreschi, K. (2016). Pathophysiologische Grundlagen der Systemtherapien bei Psoriasis. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 14(6), 557-73. https://doi.org/10.1111/ddg.13050_g
Volc, Sebastian, and Ghoreschi, Kamran. "Pathophysiologische Grundlagen der Systemtherapien bei Psoriasis." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 14,6 (2016): 557-73. doi: https://doi.org/10.1111/ddg.13050_g
Volc S, Ghoreschi K. Pathophysiologische Grundlagen der Systemtherapien bei Psoriasis. J Dtsch Dermatol Ges. 2016 Jun;14(6):557-73. doi: 10.1111/ddg.13050_g. PMID: 27240059.
Copy Download .nbib Format: NLM
Advances in treating psoriasis.

F1000prime reports

Belge K, Brück J, Ghoreschi K.
PMID: 24592316
F1000Prime Rep. 2014 Jan 02;6:4. doi: 10.12703/P6-4. eCollection 2014.

Psoriasis is a T helper (Th)17/Th1-mediated autoimmune disease affecting the skin and joints. So far, distinct traditional oral compounds and modern biologics have been approved in most countries for the treatment of patients with moderate to severe psoriasis or...

Cite
Belge K, Brück J, Ghoreschi K. Advances in treating psoriasis. F1000Prime Rep. 2014;6:4doi: 10.12703/P6-4.
Belge, K., Brück, J., & Ghoreschi, K. (2014). Advances in treating psoriasis. F1000prime reports, 64. https://doi.org/10.12703/P6-4
Belge, Katharina, et al. "Advances in treating psoriasis." F1000prime reports vol. 6 (2014): 4. doi: https://doi.org/10.12703/P6-4
Belge K, Brück J, Ghoreschi K. Advances in treating psoriasis. F1000Prime Rep. 2014 Jan 02;6:4. doi: 10.12703/P6-4. eCollection 2014. PMID: 24592316; PMCID: PMC3883421.
Copy Download .nbib Format: NLM
Alopecia areata - Current understanding and management.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume-Peytavi U.
PMID: 35040577
J Dtsch Dermatol Ges. 2022 Jan;20(1):59-90. doi: 10.1111/ddg.14689.

Alopecia areata (AA) is a chronic, immune-mediated disease characterized by acute or chronic non-scarring hair loss, with a heterogeneity in clinical manifestations ranging from patchy hair loss to complete scalp and body hair loss. An overview of the up-to-date...

Cite
Lintzeri DA, Constantinou A, Hillmann K, et al. Alopecia areata - Current understanding and management. J Dtsch Dermatol Ges. 2022;20(1):59-90doi: 10.1111/ddg.14689.
Lintzeri, D. A., Constantinou, A., Hillmann, K., Ghoreschi, K., Vogt, A., & Blume-Peytavi, U. (2022). Alopecia areata - Current understanding and management. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 20(1), 59-90. https://doi.org/10.1111/ddg.14689
Lintzeri, Dimitra Aikaterini, et al. "Alopecia areata - Current understanding and management." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 20,1 (2022): 59-90. doi: https://doi.org/10.1111/ddg.14689
Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume-Peytavi U. Alopecia areata - Current understanding and management. J Dtsch Dermatol Ges. 2022 Jan;20(1):59-90. doi: 10.1111/ddg.14689. PMID: 35040577.
Copy Download .nbib Format: NLM
The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study.

Therapeutic advances in musculoskeletal disease

Redeker I, Siegmund B, Ghoreschi K, Pleyer U, Callhoff J, Hoffmann F, Marschall U, Haibel H, Sieper J, Zink A, Poddubnyy D.
PMID: 33281952
Ther Adv Musculoskelet Dis. 2020 Nov 21;12:1759720X20972610. doi: 10.1177/1759720X20972610. eCollection 2020.

OBJECTIVE: The aim of this study was to investigate the association of extra-musculoskeletal manifestations (EMMs) with disease activity, functional status, and treatment patterns in a large population-based cohort of patients with axial spondyloarthritis (axSpA).METHODS: A stratified random sample of...

Cite
Redeker I, Siegmund B, Ghoreschi K, et al. The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study. Ther Adv Musculoskelet Dis. 2020;12:1759720X20972610doi: 10.1177/1759720X20972610.
Redeker, I., Siegmund, B., Ghoreschi, K., Pleyer, U., Callhoff, J., Hoffmann, F., Marschall, U., Haibel, H., Sieper, J., Zink, A., & Poddubnyy, D. (2020). The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study. Therapeutic advances in musculoskeletal disease, 121759720X20972610. https://doi.org/10.1177/1759720X20972610
Redeker, Imke, et al. "The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study." Therapeutic advances in musculoskeletal disease vol. 12 (2020): 1759720X20972610. doi: https://doi.org/10.1177/1759720X20972610
Redeker I, Siegmund B, Ghoreschi K, Pleyer U, Callhoff J, Hoffmann F, Marschall U, Haibel H, Sieper J, Zink A, Poddubnyy D. The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study. Ther Adv Musculoskelet Dis. 2020 Nov 21;12:1759720X20972610. doi: 10.1177/1759720X20972610. eCollection 2020. PMID: 33281952; PMCID: PMC7682214.
Copy Download .nbib Format: NLM
Targeting Immune Checkpoints and Cytokines to Protect From Psoriasis Relapse.

JAMA dermatology

Ghoreschi K.
PMID: 34643654
JAMA Dermatol. 2021 Nov 01;157(11):1269-1271. doi: 10.1001/jamadermatol.2021.3491.

No abstract available.

Cite
Ghoreschi K. Targeting Immune Checkpoints and Cytokines to Protect From Psoriasis Relapse. JAMA Dermatol. 2021;157(11):1269-1271doi: 10.1001/jamadermatol.2021.3491.
Ghoreschi, K. (2021). Targeting Immune Checkpoints and Cytokines to Protect From Psoriasis Relapse. JAMA dermatology, 157(11), 1269-1271. https://doi.org/10.1001/jamadermatol.2021.3491
Ghoreschi, Kamran. "Targeting Immune Checkpoints and Cytokines to Protect From Psoriasis Relapse." JAMA dermatology vol. 157,11 (2021): 1269-1271. doi: https://doi.org/10.1001/jamadermatol.2021.3491
Ghoreschi K. Targeting Immune Checkpoints and Cytokines to Protect From Psoriasis Relapse. JAMA Dermatol. 2021 Nov 01;157(11):1269-1271. doi: 10.1001/jamadermatol.2021.3491. PMID: 34643654.
Copy Download .nbib Format: NLM
A niche in the spotlight: Could external factors critically disturb hair follicle homeostasis and contribute to inflammatory hair follicle diseases?.

Experimental dermatology

Vogt A, Constantinou A, Rancan F, Ghoreschi K, Blume-Peytavi U, Combadiere B.
PMID: 33090548
Exp Dermatol. 2020 Oct 08; doi: 10.1111/exd.14212. Epub 2020 Oct 08.

The anatomy of the hair follicle and the dynamics of its barrier provide a special space for interactions between macromolecules and the underlying tissue. Translocation across the hair follicle epithelium and immune recognition have been confirmed for proteins, nucleic...

Cite
Vogt A, Constantinou A, Rancan F, et al. A niche in the spotlight: Could external factors critically disturb hair follicle homeostasis and contribute to inflammatory hair follicle diseases?. Exp Dermatol. 2020;doi: 10.1111/exd.14212.
Vogt, A., Constantinou, A., Rancan, F., Ghoreschi, K., Blume-Peytavi, U., & Combadiere, B. (2020). A niche in the spotlight: Could external factors critically disturb hair follicle homeostasis and contribute to inflammatory hair follicle diseases?. Experimental dermatology, . https://doi.org/10.1111/exd.14212
Vogt, Annika, et al. "A niche in the spotlight: Could external factors critically disturb hair follicle homeostasis and contribute to inflammatory hair follicle diseases?." Experimental dermatology vol. (2020). doi: https://doi.org/10.1111/exd.14212
Vogt A, Constantinou A, Rancan F, Ghoreschi K, Blume-Peytavi U, Combadiere B. A niche in the spotlight: Could external factors critically disturb hair follicle homeostasis and contribute to inflammatory hair follicle diseases?. Exp Dermatol. 2020 Oct 08; doi: 10.1111/exd.14212. Epub 2020 Oct 08. PMID: 33090548.
Copy Download .nbib Format: NLM
[No title available]

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Schnabl SM, Ghoreschi FC, Scheu A, Kofler L, Häfner HM, Breuninger H.
PMID: 33586882
J Dtsch Dermatol Ges. 2021 Feb;19(2):185-196. doi: 10.1111/ddg.14434_g.

No abstract available.

Cite
Schnabl SM, Ghoreschi FC, Scheu A, et al. Verwendung von Lokalanästhetika mit Adrenalinzusatz an den Fingern und am Penis - Dogma und Realität. . J Dtsch Dermatol Ges. 2021;19(2):185-196doi: 10.1111/ddg.14434_g.
Schnabl, S. M., Ghoreschi, F. C., Scheu, A., Kofler, L., Häfner, H. M., & Breuninger, H. (2021). Verwendung von Lokalanästhetika mit Adrenalinzusatz an den Fingern und am Penis - Dogma und Realität. . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 19(2), 185-196. https://doi.org/10.1111/ddg.14434_g
Schnabl, Saskia Maria, et al. "Verwendung von Lokalanästhetika mit Adrenalinzusatz an den Fingern und am Penis - Dogma und Realität." . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 19,2 (2021): 185-196. doi: https://doi.org/10.1111/ddg.14434_g
Schnabl SM, Ghoreschi FC, Scheu A, Kofler L, Häfner HM, Breuninger H. Verwendung von Lokalanästhetika mit Adrenalinzusatz an den Fingern und am Penis - Dogma und Realität. . J Dtsch Dermatol Ges. 2021 Feb;19(2):185-196. doi: 10.1111/ddg.14434_g. German. PMID: 33586882.
Copy Download .nbib Format: NLM
[No title available]

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Haustein UF, Ghoreschi K, Elsner P.
PMID: 33860999
J Dtsch Dermatol Ges. 2021 Apr;19(4):647-648. doi: 10.1111/ddg.14488_g.

No abstract available.

Cite
Haustein UF, Ghoreschi K, Elsner P. Prof. Dr. Niels Sönnichsen mit 90 Jahren verstorben. . J Dtsch Dermatol Ges. 2021;19(4):647-648doi: 10.1111/ddg.14488_g.
Haustein, U. F., Ghoreschi, K., & Elsner, P. (2021). Prof. Dr. Niels Sönnichsen mit 90 Jahren verstorben. . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 19(4), 647-648. https://doi.org/10.1111/ddg.14488_g
Haustein, Uwe-Frithjof, et al. "Prof. Dr. Niels Sönnichsen mit 90 Jahren verstorben." . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 19,4 (2021): 647-648. doi: https://doi.org/10.1111/ddg.14488_g
Haustein UF, Ghoreschi K, Elsner P. Prof. Dr. Niels Sönnichsen mit 90 Jahren verstorben. . J Dtsch Dermatol Ges. 2021 Apr;19(4):647-648. doi: 10.1111/ddg.14488_g. German. PMID: 33860999.
Copy Download .nbib Format: NLM
[No title available]

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Lauffer F, Eyerich K, Boehncke WH, Asadullah K, Beissert S, Ghoreschi K, Schön MP.
PMID: 32713148
J Dtsch Dermatol Ges. 2020 Jul;18(7):675-681. doi: 10.1111/ddg.14124_g.

No abstract available.

Cite
Lauffer F, Eyerich K, Boehncke WH, et al. Zytokine der IL-17-Familie bei der Psoriasis. . J Dtsch Dermatol Ges. 2020;18(7):675-681doi: 10.1111/ddg.14124_g.
Lauffer, F., Eyerich, K., Boehncke, W. H., Asadullah, K., Beissert, S., Ghoreschi, K., & Schön, M. P. (2020). Zytokine der IL-17-Familie bei der Psoriasis. . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 18(7), 675-681. https://doi.org/10.1111/ddg.14124_g
Lauffer, Felix, et al. "Zytokine der IL-17-Familie bei der Psoriasis." . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 18,7 (2020): 675-681. doi: https://doi.org/10.1111/ddg.14124_g
Lauffer F, Eyerich K, Boehncke WH, Asadullah K, Beissert S, Ghoreschi K, Schön MP. Zytokine der IL-17-Familie bei der Psoriasis. . J Dtsch Dermatol Ges. 2020 Jul;18(7):675-681. doi: 10.1111/ddg.14124_g. German. PMID: 32713148.
Copy Download .nbib Format: NLM
Characteristics of dermatomyositis patients with and without associated malignancy.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Lauinger J, Ghoreschi K, Volc S.
PMID: 34738719
J Dtsch Dermatol Ges. 2021 Nov;19(11):1601-1611. doi: 10.1111/ddg.14566. Epub 2021 Nov 05.

BACKGROUND: Dermatomyositis belongs to the rare idiopathic, inflammatory myositis group. A previously postulated link between some cases of dermatomyositis and malignancy has been established in recent years. Criteria suggestive of a malignancy association are still being explored.PATIENTS AND METHODS:...

Cite
Lauinger J, Ghoreschi K, Volc S. Characteristics of dermatomyositis patients with and without associated malignancy. J Dtsch Dermatol Ges. 2021;19(11):1601-1611doi: 10.1111/ddg.14566.
Lauinger, J., Ghoreschi, K., & Volc, S. (2021). Characteristics of dermatomyositis patients with and without associated malignancy. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 19(11), 1601-1611. https://doi.org/10.1111/ddg.14566
Lauinger, Julia, et al. "Characteristics of dermatomyositis patients with and without associated malignancy." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 19,11 (2021): 1601-1611. doi: https://doi.org/10.1111/ddg.14566
Lauinger J, Ghoreschi K, Volc S. Characteristics of dermatomyositis patients with and without associated malignancy. J Dtsch Dermatol Ges. 2021 Nov;19(11):1601-1611. doi: 10.1111/ddg.14566. Epub 2021 Nov 05. PMID: 34738719.
Copy Download .nbib Format: NLM
Charakteristika von Dermatomyositis-Patienten mit und ohne Malignom-Assoziation.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Lauinger J, Ghoreschi K, Volc S.
PMID: 34811902
J Dtsch Dermatol Ges. 2021 Nov;19(11):1601-1612. doi: 10.1111/ddg.14566_g.

HINTERGRUND: Die Dermatomyositis gehört zur Gruppe der seltenen, idiopathischen, inflammatorischen Myositiden. Für die paraneoplastische Form der Dermatomyositis wurde in der Vergangenheit ein Zusammenhang mit Malignomen erkannt. Faktoren, die für eine Malignom-Assoziation sprechen, werden bis heute untersucht.PATIENTEN UND METHODIK: Es...

Cite
Lauinger J, Ghoreschi K, Volc S. Charakteristika von Dermatomyositis-Patienten mit und ohne Malignom-Assoziation. J Dtsch Dermatol Ges. 2021;19(11):1601-1612doi: 10.1111/ddg.14566_g.
Lauinger, J., Ghoreschi, K., & Volc, S. (2021). Charakteristika von Dermatomyositis-Patienten mit und ohne Malignom-Assoziation. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 19(11), 1601-1612. https://doi.org/10.1111/ddg.14566_g
Lauinger, Julia, et al. "Charakteristika von Dermatomyositis-Patienten mit und ohne Malignom-Assoziation." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 19,11 (2021): 1601-1612. doi: https://doi.org/10.1111/ddg.14566_g
Lauinger J, Ghoreschi K, Volc S. Charakteristika von Dermatomyositis-Patienten mit und ohne Malignom-Assoziation. J Dtsch Dermatol Ges. 2021 Nov;19(11):1601-1612. doi: 10.1111/ddg.14566_g. PMID: 34811902.
Copy Download .nbib Format: NLM
The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis-Real-World Data from Dermatology Practice.

Journal of personalized medicine

Kokolakis G, Sabat R, Fischer I, Gomis-Kleindienst S, Fritz B, Burmester GR, Ghoreschi K, Ohrndorf S.
PMID: 34834435
J Pers Med. 2021 Oct 25;11(11). doi: 10.3390/jpm11111083.

Patients with psoriatic arthritis (PsA) often develop joint symptoms years after their initial diagnosis of psoriasis disease; therefore, dermatologists should test for and detect PsA early. In this study, we focused on patients with psoriasis with both nail and...

Cite
Kokolakis G, Sabat R, Fischer I, et al. The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis-Real-World Data from Dermatology Practice. J Pers Med. 2021;11(11)doi: 10.3390/jpm11111083.
Kokolakis, G., Sabat, R., Fischer, I., Gomis-Kleindienst, S., Fritz, B., Burmester, G. R., Ghoreschi, K., & Ohrndorf, S. (2021). The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis-Real-World Data from Dermatology Practice. Journal of personalized medicine, 11(11), . https://doi.org/10.3390/jpm11111083
Kokolakis, Georgios, et al. "The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis-Real-World Data from Dermatology Practice." Journal of personalized medicine vol. 11,11 (2021). doi: https://doi.org/10.3390/jpm11111083
Kokolakis G, Sabat R, Fischer I, Gomis-Kleindienst S, Fritz B, Burmester GR, Ghoreschi K, Ohrndorf S. The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis-Real-World Data from Dermatology Practice. J Pers Med. 2021 Oct 25;11(11). doi: 10.3390/jpm11111083. PMID: 34834435; PMCID: PMC8620057.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 37 entries